Swedish Orphan Biovitrum

Leadership moves, last update 2 weeks ago

Pharma biotech · Headquarters Stockholm, Sweden

Everything we hold on Swedish Orphan Biovitrum, newest first. Every line links to the filing or report it came from.

This profile is thin because we hold one source document on Swedish Orphan Biovitrum so far, not because nothing else has happened there. We only publish what we have read on a primary source and can link to. So a profile fills up as filings and reports come in, and we never seed it from an estimate. We keep profiles at this stage out of our sitemap and mark them noindex until they carry enough to be worth a search result of their own.

1. 2026-08-03
   Headcount Not Stated Leadership moves

   Sobi’s dealmaker CEO exits for BioNTech

   Guido Oelkers moves from Swedish Orphan Biovitrum to become BioNTech's CEO by Feb. 1, 2027, succeeding co-founder Uğur Şahin, an executive-suite transition that leaves Sobi needing new top leadership after Oelkers' nine-year run. The announcement names no other hiring plans.

   Stockholm, Sweden · News Report · European Biotechnology Magazine · archived copy

The read-through on each line is our interpretation. The headline and figures come from the linked source. Data licensed CC BY 4.0. Back to the tracker